Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases.

Kale, Vijay Pralhad; Hengst, Jeremy A; Sharma, Arati K; Golla, Upendarrao; Dovat, Sinisa; Amin, Shantu G; Yun, Jong K; Desai, Dhimant H

Kale, Vijay Pralhad; Hengst, Jeremy A; Sharma, Arati K; Golla, Upendarrao; Dovat, Sinisa; Amin, Shantu G; Yun, Jong K; Desai, Dhimant H.

Afiliação

Kale VP; Department of Pharmacology Penn State College of Medicine, Hershey, PA 17033, USA.
Hengst JA; Department of Pharmacology Penn State College of Medicine, Hershey, PA 17033, USA.
Sharma AK; Department of Pharmacology Penn State College of Medicine, Hershey, PA 17033, USA.
Golla U; Department of Medicine, Penn State College of Medicine, Hershey, PA 17033, USA.
Dovat S; Department of Pediatrics, Penn State College of Medicine, Hershey, PA 17033, USA.
Amin SG; Department of Pharmacology Penn State College of Medicine, Hershey, PA 17033, USA.
Yun JK; Department of Pharmacology Penn State College of Medicine, Hershey, PA 17033, USA.
Desai DH; Department of Pharmacology Penn State College of Medicine, Hershey, PA 17033, USA.

Pharmaceuticals (Basel) ; 16(8)2023 Jul 26.

Article em En | MEDLINE | ID: mdl-37630974

Palavras-chave

MRCK; ROCK; cancer; invasion; metastasis; multi-kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google